Call for Abstract
Scientific Program
37th World Cancer Conference, will be organized around the theme “Innovations and Novel Approaches in Diagnosis and Treatment of different Cancers”
World Cancer 2019 is comprised of 24 tracks and 111 sessions designed to offer comprehensive sessions that address current issues in World Cancer 2019.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Cancer Stem Cells
- Track 1-2Stem Cell Transplantation
- Track 1-3Bone Marrow Transplantation
- Track 1-4CSCs and Cancer Treatment
- Track 7-1Nutrition and Supplements
- Track 7-2Diet and exercise
- Track 7-3Cancer and Environment
- Track 8-1Oncogenesis
- Track 8-2Avoiding Risk Factors
- Track 8-3Changing Lifestyle Choices
- Track 8-4Preclinical & Clinical Research
- Track 8-5Early Detection Research
- Track 8-6Immunoprevention
- Track 8-7Chemo preventive Measures
- Track 9-1Aromatherapy
- Track 9-2Ayurveda
- Track 9-3Reflexology
- Track 9-4Art & Music Therapy
- Track 9-5Homeopathic Medicines
- Track 9-6Naturopathy
- Track 9-7Anti-Cancer Agents in Medicinal Chemistry
- Track 9-8Acupuncture
- Track 10-1Patient Assessment & Education
- Track 10-2Management & Palliative Care
- Track 10-3Assessing Physical & Emotional Status
- Track 10-4Treatment Plans
- Track 10-5Symptom Management
- Track 10-6Supportive Care
- Track 10-7Direct Patient Care
- Track 11-1Host-Tumour Relation
- Track 11-2Cancer Immunosurveillance and Immunoediting
- Track 11-3Clinical Cancer immunology
- Track 11-4Cancer Antigens & Vaccines
- Track 11-5Cellular Immunotherapy
- Track 11-6Antibody Therapy
- Track 11-7Cytokine Therapy
- Track 11-8Combination & Combinatorial Ablation and Immunotherapies
- Track 12-1Radiation Therapy
- Track 12-2Immunotherapy
- Track 12-3Targeted Cancer Therapies and Treatment
- Track 12-4Stem Cell Therapy
- Track 12-5Cancer Surgery
- Track 12-6Hormonal Therapy
- Track 12-7Precision Medicine
- Track 12-8Palliative Care & Treatment
- Track 13-1Cancer Etiology
- Track 13-2Health Disparities
- Track 13-3Genetic and molecular epidemiology
- Track 13-4Environmental Carcinogens
- Track 13-5Gene-Environment Interactions
- Track 13-6Cancer Risk Prediction
- Track 14-1Physiology & Cancer History
- Track 14-2Identifying Risk Factors
- Track 14-3Cancer Genomics & Biologic Factors
- Track 14-4Targeted Agents & Conventional Treatment
- Track 14-5New Genotyping Technologies
- Track 15-1Medical Oncology
- Track 15-2Surgical Oncology-Surgical Techniques, General & Gynaec-onco surgeries, Radical procedures, Surgical Biopsies, Reconstructive Surgery
- Track 15-3Radiation Oncology-Radiation Therapies & Techniques, Medical Imaging, Radiobiology, Nuclear Medicine, Radiation Physics, Curative Radiation Therapy
- Track 15-4Gynaecologic Oncology
- Track 15-5Paediatric Oncology
- Track 15-6Hematologic Oncology
- Track 15-7Clinical Oncology
- Track 15-8Neuro-oncology
- Track 15-9Uro-Oncology
- Track 15-10Dermato Oncology
- Track 16-1Treatment strategies
- Track 16-2Adverse effects
- Track 16-3Limitations
- Track 16-4Cancer Therapeutics, Novel and experimental approaches
- Track 17-1Clinical Toxicology
- Track 17-2Pharmacokinetics
- Track 17-3Pharmacodynamics
- Track 17-4Drug interactions
- Track 17-5Cancer Drug Targets
- Track 17-6Molecular Carcinogenesis
- Track 17-7Biochemical Pharmacology
- Track 17-8Clinical Pharmacology
- Track 18-1Cancer Microenvironment
- Track 18-2Chemo Drugs
- Track 18-3Stealth Nanoparticles and Tumor Penetrating Peptides
- Track 18-4Vector/Host Interaction
- Track 18-5New Nanomaterials
- Track 18-6Imaging and Theranostics
- Track 18-7Early Diagnosis and Imaging
- Track 18-8Advances in Nanotechnology
- Track 19-1CAR T-Cell Therapy
- Track 19-2Oncolytic viral therapies
- Track 19-3Gene therapy
- Track 19-4Adoptive T-Cell transfer
- Track 19-5Oncoviruses
- Track 19-6Therapeutic Cancer Vaccines
- Track 19-7HPV & Hepatitis B vaccine
- Track 19-8Personalised Cancer Vaccines
- Track 19-9Clinical Trails
- Track 20-1Diagnostic Biomarkers
- Track 20-2Tumour Suppressors Biomarkers
- Track 20-3Predictive & Prognostic Biomarkers
- Track 20-4Companion Biomarker
- Track 20-5Biomarkers in Cancer Research
- Track 20-6Biomarkers in Medicine
- Track 20-7Biomarkers in Cancer Medicine
- Track 20-8Risk assessment, Diagnosis
- Track 20-9Prognosis, Screening and treatment predictions
- Track 20-10Pharmacodynamics and pharmacokinetics
- Track 20-11Molecular cancer biomarkers
- Track 21-1Breast Cancer, Gastrointestinal Cancer, Gynaecologic Cancers -Cervical Cancer, Uterus Cancer, Ovarian Cancer, Vulvar Cancer, Brain Cancer, Bone Cancer, Prostate Cancer, Lung Cancer, Lymphoma, Leukaemia, Liver Cancer, Blood Cancer, Eye Cancer, Skin Cancer
- Track 22-1Tumor Biology
- Track 22-2Cancer Epigenetics
- Track 22-3Oncogenes & Proto-oncogenes
- Track 22-4Tumour Suppressor Genes